Saved in:
| Main Authors: | Jennifer Dunsmore, Eilidh Duncan, Sara J. MacLennan, James N'Dow, Philip Cornford, Francesco Esperto, Nicola Pavan, María J. Ribal, Monique J. Roobol, Ted A. Skolarus, Steven MacLennan |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.411 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
by: Sofia Mesquita, et al.
Published: (2025)
by: Sofia Mesquita, et al.
Published: (2025)
Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
by: Jonathon Dawson, et al.
Published: (2024)
by: Jonathon Dawson, et al.
Published: (2024)
The impact of vaporization on adenoma weight in benign prostatic hyperplasia surgery
by: André B. Silva, et al.
Published: (2026)
by: André B. Silva, et al.
Published: (2026)
Transperineal prostate biopsy with freehand technique under local anaesthetic: A systematic review and meta‐analysis
by: Benjamin M. Mac Curtain, et al.
Published: (2025)
by: Benjamin M. Mac Curtain, et al.
Published: (2025)
Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
by: Esther H. J. Hamoen, et al.
Published: (2025)
by: Esther H. J. Hamoen, et al.
Published: (2025)
Extended versus limited pelvic lymph node dissection and long‐term outcomes in high‐risk prostate cancer before radiotherapy
by: Georgios Daouacher, et al.
Published: (2026)
by: Georgios Daouacher, et al.
Published: (2026)
Emerging tools for the early detection of prostate cancer
by: Muhammad Haider, et al.
Published: (2025)
by: Muhammad Haider, et al.
Published: (2025)
Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
by: Ailene E. Corona, et al.
Published: (2026)
by: Ailene E. Corona, et al.
Published: (2026)
Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
by: Maxwell Louis Sandberg, et al.
Published: (2026)
by: Maxwell Louis Sandberg, et al.
Published: (2026)
Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
by: Ruth Pidsley, et al.
Published: (2024)
by: Ruth Pidsley, et al.
Published: (2024)
Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
by: Eric Margolis, et al.
Published: (2025)
by: Eric Margolis, et al.
Published: (2025)
‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
by: Ryan Sutherland, et al.
Published: (2024)
by: Ryan Sutherland, et al.
Published: (2024)
Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
by: Mathew Thakur, et al.
Published: (2024)
by: Mathew Thakur, et al.
Published: (2024)
Incorporating the NICE Cambridge Prognostic Groups and Predict Prostate into a structured informed‐decision making clinic reduces over‐treatment rates of early prostate cancer
by: Vincent J. Gnanapragasam, et al.
Published: (2025)
by: Vincent J. Gnanapragasam, et al.
Published: (2025)
Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
by: Muhammad Haider, et al.
Published: (2025)
by: Muhammad Haider, et al.
Published: (2025)
The carbon footprint of transperineal prostate biopsy
by: Daniel A. Carson, et al.
Published: (2025)
by: Daniel A. Carson, et al.
Published: (2025)
Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
by: Sophia M. Abusamra, et al.
Published: (2025)
by: Sophia M. Abusamra, et al.
Published: (2025)
Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
by: Abel Tesfai, et al.
Published: (2024)
by: Abel Tesfai, et al.
Published: (2024)
Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
by: Ansh Bhatia, et al.
Published: (2024)
by: Ansh Bhatia, et al.
Published: (2024)
Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
by: Ali H. Zahalka, et al.
Published: (2024)
by: Ali H. Zahalka, et al.
Published: (2024)
Bibliometric analysis of focal therapy in prostate cancer research
by: Mohammed Shahait, et al.
Published: (2024)
by: Mohammed Shahait, et al.
Published: (2024)
Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
by: Eric V. Li, et al.
Published: (2024)
by: Eric V. Li, et al.
Published: (2024)
National survey of urologists' views on prostate cancer screening in the United Kingdom
by: Nikhil Mayor, et al.
Published: (2026)
by: Nikhil Mayor, et al.
Published: (2026)
Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
by: Nadia Rokan, et al.
Published: (2025)
by: Nadia Rokan, et al.
Published: (2025)
Multidisciplinary meetings for lower urinary tract symptoms and benign prostate hyperplasia
by: Emilien Seizilles de Mazancourt, et al.
Published: (2025)
by: Emilien Seizilles de Mazancourt, et al.
Published: (2025)
WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
by: Mohamad Baker Berjaoui, et al.
Published: (2024)
by: Mohamad Baker Berjaoui, et al.
Published: (2024)
The significant costs of prostate cancer management—An analysis from a Caribbean hospital
by: Geneva Pantoja, et al.
Published: (2025)
by: Geneva Pantoja, et al.
Published: (2025)
Evaluating the utility of the HAS‐BLED bleeding‐estimator tool for transurethral resection of prostate
by: Lu Yu Kuo, et al.
Published: (2025)
by: Lu Yu Kuo, et al.
Published: (2025)
Risk factors of negative prostate biopsies: A CHAID decision tree analysis
by: Pierre Allainguillaume, et al.
Published: (2026)
by: Pierre Allainguillaume, et al.
Published: (2026)
Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
by: Jeremy Cheng, et al.
Published: (2025)
by: Jeremy Cheng, et al.
Published: (2025)
Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
by: Samantha Shekar, et al.
Published: (2025)
by: Samantha Shekar, et al.
Published: (2025)
A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
by: Marcus Sondermann, et al.
Published: (2025)
by: Marcus Sondermann, et al.
Published: (2025)
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
by: Arjun Pon Avudaiappan, et al.
Published: (2024)
by: Arjun Pon Avudaiappan, et al.
Published: (2024)
AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
by: Muhammad Imran, et al.
Published: (2026)
by: Muhammad Imran, et al.
Published: (2026)
Potential gains from radical treatment of men with prostate cancer according to life expectancy
by: Sandra Irenaeus, et al.
Published: (2025)
by: Sandra Irenaeus, et al.
Published: (2025)
Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm
by: Alan Priester, et al.
Published: (2024)
by: Alan Priester, et al.
Published: (2024)
Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
by: Austin Drysch, et al.
Published: (2025)
by: Austin Drysch, et al.
Published: (2025)
Perioperative alpha blockers in voiding dysfunction secondary to prostate biopsy: A meta‐analysis
by: Sean Lim, et al.
Published: (2024)
by: Sean Lim, et al.
Published: (2024)
MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
by: Herbert Lepor, et al.
Published: (2025)
by: Herbert Lepor, et al.
Published: (2025)
Anatomical distribution of disease in pN1 prostate cancer with BCR post‐RP: A PSMA‐PET/CT‐based analysis
by: Lotte G. Zuur, et al.
Published: (2025)
by: Lotte G. Zuur, et al.
Published: (2025)
Similar Items
-
Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
by: Sofia Mesquita, et al.
Published: (2025) -
Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
by: Jonathon Dawson, et al.
Published: (2024) -
The impact of vaporization on adenoma weight in benign prostatic hyperplasia surgery
by: André B. Silva, et al.
Published: (2026) -
Transperineal prostate biopsy with freehand technique under local anaesthetic: A systematic review and meta‐analysis
by: Benjamin M. Mac Curtain, et al.
Published: (2025) -
Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
by: Esther H. J. Hamoen, et al.
Published: (2025)